Hyundai Bioscience Co. Ltd (048410) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.018x

Based on the latest financial reports, Hyundai Bioscience Co. Ltd (048410) has a cash flow conversion efficiency ratio of -0.018x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.05 Billion ≈ $-1.39 Million USD) by net assets (₩111.98 Billion ≈ $75.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hyundai Bioscience Co. Ltd net asset quality index to measure how much of total assets are equity-financed.

Hyundai Bioscience Co. Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Hyundai Bioscience Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 048410 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Hyundai Bioscience Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hyundai Bioscience Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Beijing Kaiwen Education Technology Co Ltd SHE:002659	0.034x
Shanxi Antai Group Co Ltd SHG:600408	0.053x
Smcp SAS PA:SMCP	0.110x
BIGLARI HLDGS CL. A F:SQ7A	N/A
Pubang Landscape Architecture Co Ltd SHE:002663	-0.003x
Nathans Famous Inc NASDAQ:NATH	-0.179x
PT Temas Tbk JK:TMAS	0.079x
Ovid Therapeutics Inc NASDAQ:OVID	-0.080x

Annual Cash Flow Conversion Efficiency for Hyundai Bioscience Co. Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Hyundai Bioscience Co. Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see 048410 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩110.73 Billion ≈ $75.04 Million	₩-17.05 Billion ≈ $-11.55 Million	-0.154x	-369.06%
2024-12-31	₩39.44 Billion ≈ $26.73 Million	₩2.26 Billion ≈ $1.53 Million	0.057x	+143.12%
2023-12-31	₩45.27 Billion ≈ $30.68 Million	₩-6.01 Billion ≈ $-4.07 Million	-0.133x	+53.28%
2022-12-31	₩58.24 Billion ≈ $39.47 Million	₩-16.54 Billion ≈ $-11.21 Million	-0.284x	-3148.24%
2021-12-31	₩61.57 Billion ≈ $41.73 Million	₩-538.48 Million ≈ $-364.92K	-0.009x	-105.97%
2020-12-31	₩51.22 Billion ≈ $34.71 Million	₩7.50 Billion ≈ $5.08 Million	0.146x	-25.02%
2019-12-31	₩46.99 Billion ≈ $31.84 Million	₩9.18 Billion ≈ $6.22 Million	0.195x	+58.00%
2018-12-31	₩40.48 Billion ≈ $27.44 Million	₩5.01 Billion ≈ $3.39 Million	0.124x	+203.33%
2017-12-31	₩30.89 Billion ≈ $20.93 Million	₩-3.70 Billion ≈ $-2.50 Million	-0.120x	+49.76%
2016-12-31	₩18.21 Billion ≈ $12.34 Million	₩-4.34 Billion ≈ $-2.94 Million	-0.238x	-6808.19%
2015-12-31	₩24.60 Billion ≈ $16.67 Million	₩87.36 Million ≈ $59.20K	0.004x	-93.48%
2014-12-31	₩22.49 Billion ≈ $15.24 Million	₩1.22 Billion ≈ $829.60K	0.054x	-80.56%
2011-12-31	₩14.17 Billion ≈ $9.61 Million	₩3.97 Billion ≈ $2.69 Million	0.280x	+35.95%
2008-12-31	₩50.36 Billion ≈ $34.13 Million	₩10.37 Billion ≈ $7.03 Million	0.206x	--

About Hyundai Bioscience Co. Ltd

KQ:048410 Korea Biotechnology

Market Cap

$403.52 Million

₩595.44 Billion KRW

Market Cap Rank

#13265 Global

#365 in Korea

Share Price

₩6200.00

Change (1 day)

+5.08%

52-Week Range

₩4595.00 - ₩20000.00

All Time High

₩54700.00